2024
Assessment of Agrimonia eupatoria L. and Lipophosphonoxin (DR-6180) Combination for Wound Repair: Bridging the Gap Between Phytomedicine and Organic Chemistry
KAŇUCHOVÁ, Miriam; Veronika BRINDZA LACHOVÁ; Kateřina BOGDANOVÁ; Jana SABOVÁ; Petra BONOVÁ et. al.Basic information
Original name
Assessment of Agrimonia eupatoria L. and Lipophosphonoxin (DR-6180) Combination for Wound Repair: Bridging the Gap Between Phytomedicine and Organic Chemistry
Authors
KAŇUCHOVÁ, Miriam (703 Slovakia, guarantor); Veronika BRINDZA LACHOVÁ (705 Slovenia); Kateřina BOGDANOVÁ (203 Czech Republic); Jana SABOVÁ (703 Slovakia); Petra BONOVÁ (703 Slovakia); Tomáš VASILENKO (703 Slovakia); Ivan KOVÁČ (703 Slovakia); Martin NOVOTNÝ (703 Slovakia); Petra MITRENGOVÁ (703 Slovakia); Nitjawan SAHATSAPAN (703 Slovakia); Matúš COMA (703 Slovakia); Emil ŠVAJDLENKA (203 Czech Republic, belonging to the institution); Milan KOLÁŘ (203 Czech Republic); Peter BOHUŠ (703 Slovakia); Pavel MUČAJI (703 Slovakia); Robert ZAJÍČEK (203 Czech Republic); Dominik REJMAN (203 Czech Republic) and Peter GÁL (703 Slovakia)
Edition
Biomolecules, Basel, Switzerland, MDPI AG, 2024, 2218-273X
Other information
Language
English
Type of outcome
Article in a journal
Field of Study
10608 Biochemistry and molecular biology
Country of publisher
Switzerland
Confidentiality degree
is not subject to a state or trade secret
References:
Impact factor
Impact factor: 4.800 in 2023
RIV identification code
RIV/00216224:14160/24:00139010
Organization unit
Faculty of Pharmacy
UT WoS
001386946400001
EID Scopus
2-s2.0-85213372135
Keywords in English
skin tissue; extracellular matrix; repair; regeneration; phytotherapy
Tags
International impact, Reviewed
Changed: 6/3/2025 12:49, Mgr. Daniela Černá
Abstract
V originále
Agrimonia eupatoria L. (AE) has a rich tradition of use in wound healing improvement across various cultures worldwide. In previous studies, we revealed that Agrimonia eupatoria L. water extract (AE) possesses a rich polyphenolic composition, displaying remarkable antioxidant properties. Our investigations also demonstrated that lipophosphonoxin (LPPO) exhibited antibacterial efficacy in vitro while preserving the proliferation and differentiation of fibroblasts and keratinocytes. Building upon our prior findings, in this study, we intended to examine whether a combination of AE and LPPO could enhance skin wound healing while retaining antibacterial attributes. The antibacterial activity of AE/LPPO against Staphylococcus aureus was evaluated, alongside its effects on fibroblast-to-myofibroblast transition, the formation of extracellular matrix (ECM), and endothelial cells and keratinocyte proliferation/phenotype. We also investigated AE/LPPO's impact on TGF-beta 1 and VEGF-A signaling in keratinocytes/fibroblasts and endothelial cells, respectively. Additionally, wound healing progression in rats was examined through macroscopic observation and histological analysis. Our results indicate that AE/LPPO promotes myofibroblast-like phenotypic changes and augments ECM deposition. Clinically relevant, the AE/LPPO did not disrupt TGF-beta 1 and VEGF-A signaling and accelerated wound closure in rats. Notably, while AE and LPPO individually exhibited antibacterial activity, their combination did not lead to synergism, rather decreasing antibacterial activity, warranting further examination. These findings underscore substantial wound healing improvement facilitated by AE/LPPO, requiring further exploration in animal models closer to human physiology.
Links
LX22NPO5103, research and development project |
|